{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:37:17Z","timestamp":1789598237410,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cancer Research Institute"},{"name":"A*STAR NSS (PhD) graduate scholarship"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA208205"],"award-info":[{"award-number":["R01CA208205"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS118929"],"award-info":[{"award-number":["R01NS118929"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100808"],"award-info":[{"award-number":["R01NS100808"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH110438"],"award-info":[{"award-number":["R01MH110438"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our recent studies uncovered a novel GABA signaling pathway in embryonic forebrain endothelial cells that works independently from neuronal GABA signaling and revealed that disruptions in endothelial GABA<jats:sub>A<\/jats:sub> receptor-GABA signaling from early embryonic stages can directly contribute to the origin of psychiatric disorders. In the GABA<jats:sub>A<\/jats:sub> receptor \u03b23 subunit endothelial cell conditional knockout (<jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup>) mice, the \u03b23 subunit is deleted selectively from endothelial cells, therefore endothelial GABA<jats:sub>A<\/jats:sub> receptors become inactivated and dysfunctional. There is a reduction in vessel densities and increased vessel morphology in the <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> telencephalon that persists in the adult neocortex. <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> mice show behavioral deficits such as impaired reciprocal social interactions, communication deficits, heightened anxiety, and depression. Here, we characterize the functional changes in <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> mice by evaluating cortical blood flow, examine the consequences of loss of endothelial <jats:italic>Gabrb3<\/jats:italic> on cardiac tissue, and define more in-depth altered behaviors. Red blood cell velocity and blood flow were increased in the cortical microcirculation of the <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> mice. The <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> mice had a reduction in vessel densities in the heart, similar to the brain; exhibited wavy, myocardial fibers, with elongated \u2018worm-like\u2019 nuclei in their cardiac histology, and developed hypertension. Additional alterations in behavioral function were observed in the <jats:italic>Gabrb3<\/jats:italic><jats:sup><jats:italic>ECKO<\/jats:italic><\/jats:sup> mice such as increased spontaneous exploratory activity and rearing in an open field, reduced short term memory, decreased ambulatory activity in CLAMS testing, and altered prepulse inhibition to startle, an important biomarker of psychiatric diseases such as schizophrenia. Our results imply that vascular <jats:italic>Gabrb3<\/jats:italic> is a key player in the brain as well as the heart, and its loss in both organs can lead to concurrent development of psychiatric and cardiac dysfunction.<\/jats:p>","DOI":"10.1038\/s41598-022-08806-9","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T20:03:26Z","timestamp":1647979406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Gabrb3 endothelial cell-specific knockout mice display abnormal blood flow, hypertension, and behavioral dysfunction"],"prefix":"10.1038","volume":"12","author":[{"given":"Anass","family":"Agrud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivan","family":"Subburaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin Srinivasan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Caldarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangde","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Fukumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"8806_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","volume":"25","author":"DA Lewis","year":"2002","unstructured":"Lewis, D. A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409\u2013432. https:\/\/doi.org\/10.1146\/annurev.neuro.25.112701.142754 (2002).","journal-title":"Annu. Rev. Neurosci."},{"key":"8806_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1192\/bjp.bp.110.084384","volume":"198","author":"MJ Owen","year":"2011","unstructured":"Owen, M. J., O\u2019Donovan, M. C., Thapar, A. & Craddock, N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 198, 173\u2013175. https:\/\/doi.org\/10.1192\/bjp.bp.110.084384 (2011).","journal-title":"Br. J. Psychiatry"},{"key":"8806_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.npp.1301569","volume":"33","author":"ED Leonardo","year":"2008","unstructured":"Leonardo, E. D. & Hen, R. Anxiety as a developmental disorder. Neuropsychopharmacology 33, 134\u2013140. https:\/\/doi.org\/10.1038\/sj.npp.1301569 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"8806_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coph.2006.11.006","volume":"7","author":"MS Ansorge","year":"2007","unstructured":"Ansorge, M. S., Hen, R. & Gingrich, J. A. Neurodevelopmental origins of depressive disorders. Curr. Opin. Pharmacol. 7, 8\u201317. https:\/\/doi.org\/10.1016\/j.coph.2006.11.006 (2007).","journal-title":"Curr. Opin. Pharmacol."},{"key":"8806_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/NDT.S58841","volume":"11","author":"P Nuss","year":"2015","unstructured":"Nuss, P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr. Dis. Treat. 11, 165\u2013175. https:\/\/doi.org\/10.2147\/NDT.S58841 (2015).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"8806_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2019.00087","volume":"13","author":"MV Fogaca","year":"2019","unstructured":"Fogaca, M. V. & Duman, R. S. Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions. Front. Cell Neurosci. 13, 87. https:\/\/doi.org\/10.3389\/fncel.2019.00087 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"8806_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/mp.2010.120","volume":"16","author":"B Luscher","year":"2011","unstructured":"Luscher, B., Shen, Q. & Sahir, N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 16, 383\u2013406. https:\/\/doi.org\/10.1038\/mp.2010.120 (2011).","journal-title":"Mol. Psychiatry"},{"key":"8806_CR8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","volume":"62","author":"K Nakazawa","year":"2012","unstructured":"Nakazawa, K. et al. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62, 1574\u20131583. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.022 (2012).","journal-title":"Neuropharmacology"},{"key":"8806_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","volume":"35","author":"DA Lewis","year":"2012","unstructured":"Lewis, D. A., Curley, A. A., Glausier, J. R. & Volk, D. W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35, 57\u201367. https:\/\/doi.org\/10.1016\/j.tins.2011.10.004 (2012).","journal-title":"Trends Neurosci."},{"key":"8806_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","volume":"131","author":"C Konradi","year":"2011","unstructured":"Konradi, C. et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 131, 165\u2013173. https:\/\/doi.org\/10.1016\/j.schres.2011.06.007 (2011).","journal-title":"Schizophr Res."},{"key":"8806_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"DA Lewis","year":"2005","unstructured":"Lewis, D. A., Hashimoto, T. & Volk, D. W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6, 312\u2013324. https:\/\/doi.org\/10.1038\/nrn1648 (2005).","journal-title":"Nat Rev Neurosci"},{"key":"8806_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fpsyt.2017.00118","volume":"8","author":"JC de Jonge","year":"2017","unstructured":"de Jonge, J. C., Vinkers, C. H., Hulshoff Pol, H. E. & Marsman, A. GABAergic mechanisms in schizophrenia: Linking postmortem and in vivo studies. Front. Psychiatry 8, 118. https:\/\/doi.org\/10.3389\/fpsyt.2017.00118 (2017).","journal-title":"Front. Psychiatry"},{"key":"8806_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.bcp.2004.07.034","volume":"68","author":"JT Coyle","year":"2004","unstructured":"Coyle, J. T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 68, 1507\u20131514. https:\/\/doi.org\/10.1016\/j.bcp.2004.07.034 (2004).","journal-title":"Biochem. Pharmacol."},{"key":"8806_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.neuropharm.2011.05.011","volume":"62","author":"AA Grace","year":"2012","unstructured":"Grace, A. A. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62, 1342\u20131348. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.05.011 (2012).","journal-title":"Neuropharmacology"},{"key":"8806_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0711-y","author":"TR Marques","year":"2020","unstructured":"Marques, T. R. et al. GABA-A receptor differences in schizophrenia: A positron emission tomography study using [(11)C]Ro154513. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-020-0711-y (2020).","journal-title":"Mol. Psychiatry"},{"key":"8806_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000054882","volume":"43","author":"G Papadimitriou","year":"2001","unstructured":"Papadimitriou, G. et al. Association between GABA-A receptor alpha 5 subunit gene locus and schizophrenia of a later age of onset. Neuropsychobiology 43, 141\u2013144. https:\/\/doi.org\/10.1159\/000054882 (2001).","journal-title":"Neuropsychobiology"},{"key":"8806_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1042\/BST0371415","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen, J. et al. GABRB2 in schizophrenia and bipolar disorder: Disease association, gene expression and clinical correlations. Biochem. Soc. Trans 37, 1415\u20131418. https:\/\/doi.org\/10.1042\/BST0371415 (2009).","journal-title":"Biochem. Soc. Trans"},{"key":"8806_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12031-017-1003-0","volume":"64","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. The GABRB3 Polymorphism and its Association with Schizophrenia. J. Mol. Neurosci. 64, 75\u201379. https:\/\/doi.org\/10.1007\/s12031-017-1003-0 (2018).","journal-title":"J. Mol. Neurosci."},{"key":"8806_CR19","doi-asserted-by":"publisher","first-page":"21973","DOI":"10.1002\/syn.21973","volume":"71","author":"SH Fatemi","year":"2017","unstructured":"Fatemi, S. H., Folsom, T. D. & Thuras, P. D. GABAA and GABAB receptor dysregulation in superior frontal cortex of subjects with schizophrenia and bipolar disorder. Synapse 71, 21973. https:\/\/doi.org\/10.1002\/syn.21973 (2017).","journal-title":"Synapse"},{"key":"8806_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2020.04.027","volume":"220","author":"A Frajman","year":"2020","unstructured":"Frajman, A. et al. Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia. Schizophr Res. 220, 29\u201337. https:\/\/doi.org\/10.1016\/j.schres.2020.04.027 (2020).","journal-title":"Schizophr Res."},{"key":"8806_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1113\/jphysiol.2008.167635","volume":"587","author":"DD Wang","year":"2009","unstructured":"Wang, D. D. & Kriegstein, A. R. Defining the role of GABA in cortical development. J. Physiol. 587, 1873\u20131879. https:\/\/doi.org\/10.1113\/jphysiol.2008.167635 (2009).","journal-title":"J. Physiol."},{"key":"8806_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s004410100356","volume":"305","author":"P Varju","year":"2001","unstructured":"Varju, P., Katarova, Z., Madarasz, E. & Szabo, G. GABA signalling during development: New data and old questions. Cell Tissue Res. 305, 239\u2013246. https:\/\/doi.org\/10.1007\/s004410100356 (2001).","journal-title":"Cell Tissue Res."},{"key":"8806_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fncir.2013.00170","volume":"7","author":"K Egawa","year":"2013","unstructured":"Egawa, K. & Fukuda, A. Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models. Front. Neural Circuits 7, 170. https:\/\/doi.org\/10.3389\/fncir.2013.00170 (2013).","journal-title":"Front. Neural Circuits"},{"key":"8806_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tins.2005.03.010","volume":"28","author":"A Represa","year":"2005","unstructured":"Represa, A. & Ben-Ari, Y. Trophic actions of GABA on neuronal development. Trends Neurosci. 28, 278\u2013283. https:\/\/doi.org\/10.1016\/j.tins.2005.03.010 (2005).","journal-title":"Trends Neurosci."},{"key":"8806_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/cr.2017.135","volume":"28","author":"S Li","year":"2018","unstructured":"Li, S. et al. Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. Cell Res. 28, 221\u2013248. https:\/\/doi.org\/10.1038\/cr.2017.135 (2018).","journal-title":"Cell Res."},{"key":"8806_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874205X01913010001","volume":"13","author":"J Baruah","year":"2019","unstructured":"Baruah, J. & Vasudevan, A. The vessels shaping mental health or illness. Open Neurol. J. 13, 1\u20139. https:\/\/doi.org\/10.2174\/1874205X01913010001 (2019).","journal-title":"Open Neurol. J."},{"key":"8806_CR27","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/ncomms3149","volume":"4","author":"C Won","year":"2013","unstructured":"Won, C. et al. Autonomous vascular networks synchronize GABA neuron migration in the embryonic forebrain. Nat. Commun. 4, 2149. https:\/\/doi.org\/10.1038\/ncomms3149 (2013).","journal-title":"Nat. Commun."},{"key":"8806_CR28","first-page":"103","volume":"36","author":"RJ Mathew","year":"1994","unstructured":"Mathew, R. J. Cerebral blood flow and metabolism in anxiety and anxiety disorders. Indian J. Psychiatry 36, 103\u2013120 (1994).","journal-title":"Indian J. Psychiatry"},{"key":"8806_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107735","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Assessing regional cerebral blood flow in depression using 320-slice computed tomography. PLoS ONE 9, e107735. https:\/\/doi.org\/10.1371\/journal.pone.0107735 (2014).","journal-title":"PLoS ONE"},{"key":"8806_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1161\/01.str.29.6.1149","volume":"29","author":"A Owega","year":"1998","unstructured":"Owega, A. et al. Cerebral blood flow velocity in acute schizophrenic patients. A transcranial Doppler ultrasonography study. Stroke 29, 1149\u20131154. https:\/\/doi.org\/10.1161\/01.str.29.6.1149 (1998).","journal-title":"Stroke"},{"key":"8806_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2350-6-7","volume":"6","author":"DR Hanson","year":"2005","unstructured":"Hanson, D. R. & Gottesman, I. I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med. Genet. 6, 7. https:\/\/doi.org\/10.1186\/1471-2350-6-7 (2005).","journal-title":"BMC Med. Genet."},{"key":"8806_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrc778","volume":"2","author":"RK Jain","year":"2002","unstructured":"Jain, R. K., Munn, L. L. & Fukumura, D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2, 266\u2013276. https:\/\/doi.org\/10.1038\/nrc778 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"8806_CR33","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1101\/pdb.prot073916","volume":"354\u2013358","author":"RK Jain","year":"2013","unstructured":"Jain, R. K., Munn, L. L. & Fukumura, D. Measuring angiogenesis and hemodynamics in mice. Cold Spring Harb. Protoc. 354\u2013358, 2013. https:\/\/doi.org\/10.1101\/pdb.prot073916 (2013).","journal-title":"Cold Spring Harb. Protoc."},{"key":"8806_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/89997","volume":"7","author":"EB Brown","year":"2001","unstructured":"Brown, E. B. et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med. 7, 864\u2013868. https:\/\/doi.org\/10.1038\/89997 (2001).","journal-title":"Nat. Med."},{"key":"8806_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnmol.2018.00018","volume":"11","author":"EA Everington","year":"2018","unstructured":"Everington, E. A., Gibbard, A. G., Swinny, J. D. & Seifi, M. Molecular characterization of GABA-A receptor subunit diversity within major peripheral organs and their plasticity in response to early life psychosocial stress. Front. Mol. Neurosci. 11, 18. https:\/\/doi.org\/10.3389\/fnmol.2018.00018 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"8806_CR36","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1515\/CCLM.2007.342","volume":"45","author":"N Tyagi","year":"2007","unstructured":"Tyagi, N. et al. Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine. Clin. Chem. Lab. Med. 45, 1777\u20131784. https:\/\/doi.org\/10.1515\/CCLM.2007.342 (2007).","journal-title":"Clin. Chem. Lab. Med."},{"key":"8806_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/CIRCRESAHA.116.308645","volume":"119","author":"S Sen","year":"2016","unstructured":"Sen, S. et al. gamma-Aminobutyric Acid Is Synthesized and Released by the Endothelium: Potential Implications. Circ. Res. 119, 621\u2013634. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308645 (2016).","journal-title":"Circ. Res."},{"key":"8806_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000169735","volume":"60","author":"FW Eichbaum","year":"1975","unstructured":"Eichbaum, F. W. \u201cWavy\u201d myocardial fibers in spontaneous and experimental adrenergic cardiopathies. Cardiology 60, 358\u2013365. https:\/\/doi.org\/10.1159\/000169735 (1975).","journal-title":"Cardiology"},{"key":"8806_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/1291","author":"A Daugherty","year":"2009","unstructured":"Daugherty, A., Rateri, D., Hong, L. & Balakrishnan, A. Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J. Vis. Exp. https:\/\/doi.org\/10.3791\/1291 (2009).","journal-title":"J. Vis. Exp."},{"issue":"Suppl 1","key":"8806_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/15622975.2011.599212","volume":"12","author":"R Donev","year":"2011","unstructured":"Donev, R. et al. Comorbidity of schizophrenia and adult attention-deficit hyperactivity disorder. World J. Biol. Psychiatry 12(Suppl 1), 52\u201356. https:\/\/doi.org\/10.3109\/15622975.2011.599212 (2011).","journal-title":"World J. Biol. Psychiatry"},{"key":"8806_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41398-018-0176-9","volume":"8","author":"RK Yeung","year":"2018","unstructured":"Yeung, R. K. et al. Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation. Transl. Psychiatry 8, 128. https:\/\/doi.org\/10.1038\/s41398-018-0176-9 (2018).","journal-title":"Transl. Psychiatry"},{"key":"8806_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevNeurobiol.v14.i1.10","volume":"14","author":"B Elvevag","year":"2000","unstructured":"Elvevag, B. & Goldberg, T. E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14, 1\u201321 (2000).","journal-title":"Crit. Rev. Neurobiol."},{"key":"8806_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3628","volume":"11","author":"MJ Millan","year":"2012","unstructured":"Millan, M. J. et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat. Rev. Drug Discov. 11, 141\u2013168. https:\/\/doi.org\/10.1038\/nrd3628 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8806_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/schbul\/23.3.437","volume":"23","author":"PS Goldman-Rakic","year":"1997","unstructured":"Goldman-Rakic, P. S. & Selemon, L. D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull. 23, 437\u2013458. https:\/\/doi.org\/10.1093\/schbul\/23.3.437 (1997).","journal-title":"Schizophr Bull."},{"key":"8806_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","volume":"281","author":"B Moghaddam","year":"1998","unstructured":"Moghaddam, B. & Adams, B. W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349\u20131352. https:\/\/doi.org\/10.1126\/science.281.5381.1349 (1998).","journal-title":"Science"},{"key":"8806_CR46","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","volume":"164","author":"CA Jones","year":"2011","unstructured":"Jones, C. A., Watson, D. J. & Fone, K. C. Animal models of schizophrenia. Br. J. Pharmacol. 164, 1162\u20131194. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01386.x (2011).","journal-title":"Br. J. Pharmacol."},{"key":"8806_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer, M. A., Krebs-Thomson, K., Braff, D. L. & Swerdlow, N. R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156, 117\u2013154. https:\/\/doi.org\/10.1007\/s002130100811 (2001).","journal-title":"Psychopharmacology"},{"key":"8806_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fnbeh.2016.00202","volume":"10","author":"A Mena","year":"2016","unstructured":"Mena, A. et al. Reduced prepulse inhibition as a biomarker of schizophrenia. Front. Behav. Neurosci. 10, 202. https:\/\/doi.org\/10.3389\/fnbeh.2016.00202 (2016).","journal-title":"Front. Behav. Neurosci."},{"key":"8806_CR49","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1523\/JNEUROSCI.18-20-08505.1998","volume":"18","author":"TM DeLorey","year":"1998","unstructured":"DeLorey, T. M. et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18, 8505\u20138514 (1998).","journal-title":"J. Neurosci."},{"key":"8806_CR50","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1152\/jn.00651.2009","volume":"102","author":"H Hentschke","year":"2009","unstructured":"Hentschke, H. et al. Altered GABAA, slow inhibition and network oscillations in mice lacking the GABAA receptor beta3 subunit. J. Neurophysiol. 102, 3643\u20133655. https:\/\/doi.org\/10.1152\/jn.00651.2009 (2009).","journal-title":"J. Neurophysiol."},{"key":"8806_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2202-8-85","volume":"8","author":"C Ferguson","year":"2007","unstructured":"Ferguson, C. et al. New insight into the role of the beta3 subunit of the GABAA-R in development, behavior, body weight regulation, and anesthesia revealed by conditional gene knockout. BMC Neurosci. 8, 85. https:\/\/doi.org\/10.1186\/1471-2202-8-85 (2007).","journal-title":"BMC Neurosci."},{"key":"8806_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13, 261\u2013276. https:\/\/doi.org\/10.1093\/schbul\/13.2.261 (1987).","journal-title":"Schizophr Bull."},{"key":"8806_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1121\/1.1910776","volume":"43","author":"HS Hoffman","year":"1968","unstructured":"Hoffman, H. S. & Searle, J. L. Acoustic and temporal factors in the evocation of startle. J. Acoust. Soc. Am. 43, 269\u2013282. https:\/\/doi.org\/10.1121\/1.1910776 (1968).","journal-title":"J. Acoust. Soc. Am."},{"key":"8806_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3758\/BF03335308","volume":"5","author":"FK Graham","year":"1977","unstructured":"Graham, F. K. & Murray, G. M. Discordant effects of weak prestimulation on magnitude and latency of the reflex blink. Physiol. Psychol. 5, 108\u2013114. https:\/\/doi.org\/10.3758\/BF03335308 (1977).","journal-title":"Physiol. Psychol."},{"key":"8806_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","volume":"20","author":"M De Hert","year":"2018","unstructured":"De Hert, M., Detraux, J. & Vancampfort, D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin. Neurosci. 20, 31\u201340 (2018).","journal-title":"Dialogues Clin. Neurosci."},{"key":"8806_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.113.006515","volume":"129","author":"C Alcantara","year":"2014","unstructured":"Alcantara, C. & Davidson, K. W. Mental disorders and coronary heart disease risk: could the evidence elude us while we sleep?. Circulation 129, 139\u2013141. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006515 (2014).","journal-title":"Circulation"},{"key":"8806_CR57","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.1073\/pnas.90.20.9355","volume":"90","author":"TN Sato","year":"1993","unstructured":"Sato, T. N., Qin, Y., Kozak, C. A. & Audus, K. L. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. U. S. A. 90, 9355\u20139358. https:\/\/doi.org\/10.1073\/pnas.90.20.9355 (1993).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"8806_CR58","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1242\/dev.119.3.957","volume":"119","author":"H Schnurch","year":"1993","unstructured":"Schnurch, H. & Risau, W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119, 957\u2013968 (1993).","journal-title":"Development"},{"key":"8806_CR59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/01.res.81.4.567","volume":"81","author":"AL Wong","year":"1997","unstructured":"Wong, A. L. et al. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 81, 567\u2013574. https:\/\/doi.org\/10.1161\/01.res.81.4.567 (1997).","journal-title":"Circ Res."},{"key":"8806_CR60","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2018.06.019","volume":"28","author":"AI Mina","year":"2018","unstructured":"Mina, A. I. et al. CalR: A web-based analysis tool for indirect calorimetry experiments. Cell Metab. 28, 656-666e651. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.019 (2018).","journal-title":"Cell Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08806-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:02:27Z","timestamp":1669338147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08806-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4922"}}